Related references
Note: Only part of the references are listed.Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial
B. C. John Cho et al.
LANCET ONCOLOGY (2021)
Commentary: Not only SMART clinically, but translationally!
Harvey I. Pass
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2020)
Prognostic influence of tumor microenvironment after hypofractionated radiation and surgery for mesothelioma
Marc de Perrot et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2020)
Mesothelioma and Radical Surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesothelioma
Eric Lim et al.
BMJ OPEN (2020)
Preoperative Identification of Benefit from Surgery for Malignant Pleural Mesothelioma
Isabelle Opitz et al.
THORACIC SURGERY CLINICS (2020)
In Situ Vaccination after Accelerated Hypofractionated Radiation and Surgery in a Mesothelioma Mouse Model
Luis De La Maza et al.
CLINICAL CANCER RESEARCH (2017)
Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial
Rolf A. Stahel et al.
LANCET ONCOLOGY (2015)
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
Tom Treasure et al.
LANCET ONCOLOGY (2011)
Share Paper
